Skip to content

Steven P. Treon, MD, PHD

NPI 1821060138ActiveIndividual· Specialist· Boston, MA

Specialist (MD, PHD) in Boston, Massachusetts, licensed in MA, with an NPI issued in February 2006. Part D covered 16 prescriptions written in 2024, 100% of them generic. Glaxosmithkline, LLC. was the largest of 5 companies reporting payments in 2025, $93,473 in all, mostly consulting fees.

Overview

NPI1821060138
StatusActive
Entity typeIndividual
CredentialMD, PHD
Sole proprietorYes
NPI issuedFeb 2, 2006
Last updated in NPPESJul 8, 2007

Specialties and licenses

TaxonomyCodeLicenseState
Specialist Primary174400000X79961MA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Medical Oncology (MA)

Part D prescriptions in 2024

Prescriptions (claims)16 · 42 30-day fills
Total drug cost$115.18
Generic share100% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$93,473 · 11 payments from 5 companies
  • 2024$78,753 · 15 payments from 4 companies

Top paying companies in 2025

What the 2025 payments were for

  • Consulting Fee$93,080 · 7 payments
  • Food and Beverage$393.14 · 4 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Specialist providers in Boston

All Specialist providers in Massachusetts →